Talphera (TLPH) Liabilities from Discontinued Operations (2022 - 2026)
Talphera (TLPH) recorded quarterly Liabilities from Discontinued Operations of 650000.0 in Q1 2026, little changed quarter-over-quarter from 650000.0 in Q4 2025, and little changed on a YoY basis from 650000.0 in Q1 2025.
Talphera (TLPH) Liabilities from Discontinued Operations (2022 - 2026) Analysis & Trends
Talphera's Liabilities from Discontinued Operations history runs 5 years deep, the most recent figure standing at 650000.0 for Q1 2026.
- In Q1 2026, Liabilities from Discontinued Operations changed 0.0% year-over-year to 650000.0; the TTM figure through Mar 2026 stood at 650000.0 (changed 0.0% YoY), while the FY2025 annual figure was 650000.0, down 10.1% from the prior year.
- Liabilities from Discontinued Operations was 650000.0 for Q1 2026 at Talphera, roughly flat from 650000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 3995000.0 in Q4 2022 to a low of 650000.0 in Q1 2025.
- Historically, Liabilities from Discontinued Operations has averaged 1179416.67 across 5 years, with a median of 723000.0 in 2024.
- The sharpest annual moves came in 2023 and 2026: Liabilities from Discontinued Operations slumped 81.7% in 2023, then changed 0.0% in 2026.
- A 5-year view of Liabilities from Discontinued Operations shows it stood at 3995000.0 in 2022, then plunged by 81.7% to 731000.0 in 2023, then dropped by 1.09% to 723000.0 in 2024, then declined by 10.1% to 650000.0 in 2025, then changed by 0.0% to 650000.0 in 2026.
- The last three Liabilities from Discontinued Operations figures came in at 650000.0 (Q1 2026), 650000.0 (Q4 2025), and 650000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Talphera | 61.00 Mn | 61.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 650,000.00 |
| Mar 31, 2026 | 650,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 650,000.00 |
| Sep 30, 2025 | 650,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Mar 31, 2025 | 650,000.00 |
| Mar 31, 2025 | 650,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Sep 30, 2024 | 723,000.00 |
| Sep 30, 2024 | 723,000.00 |
| Jun 30, 2024 | 723,000.00 |
| Jun 30, 2024 | 723,000.00 |
| Mar 31, 2024 | 730,000.00 |
| Mar 31, 2024 | 730,000.00 |
| Dec 31, 2023 | 731,000.00 |
| Dec 31, 2023 | 731,000.00 |